SSA
IMUX icon

Schonfeld Strategic Advisors’s Immunic IMUX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.4K Buy
+2,830
New +$25.3K ﹤0.01% 2019
2025
Q2 		– Sell
-4,577
Closed -$49.9K – 2259
2025
Q1 		$49.9K Buy
+4,577
New +$49.4K ﹤0.01% 2072
2024
Q4 		– Sell
-1,660
Closed -$27.4K – 2188
2024
Q3 		$27.4K Sell
1,660
-1,160
-41% -$16.5K ﹤0.01% 1913
2024
Q2 		$31.3K Sell
2,820
-2,480
-47% -$30.8K ﹤0.01% 1978
2024
Q1 		$70K Sell
5,300
-7,670
-59% -$99.7K ﹤0.01% 1879
2023
Q4 		$195K Sell
12,970
-10,900
-46% -$134K ﹤0.01% 1538
2023
Q3 		$351K Buy
23,870
+6,380
+36% +$123K ﹤0.01% 1296
2023
Q2 		$439K Buy
17,490
+4,190
+32% +$70.2K ﹤0.01% 1268
2023
Q1 		$198K Buy
+13,300
New +$247K ﹤0.01% 1547
2022
Q4 		– Sell
-10,440
Closed -$330K – 2794
2022
Q3 		$330K Buy
10,440
+270
+3% +$11.3K ﹤0.01% 2020
2022
Q2 		$353K Buy
10,170
+2,070
+26% +$133K ﹤0.01% 1563
2022
Q1 		$916K Buy
8,100
+2,470
+44% +$286K 0.01% 1037
2021
Q4 		$539K Buy
5,630
+190
+3% +$17.1K ﹤0.01% 1222
2021
Q3 		$482K Buy
5,440
+350
+7% +$34.4K 0.01% 1294
2021
Q2 		$624K Buy
5,090
+880
+21% +$122K 0.01% 1089
2021
Q1 		$671K Buy
4,210
+250
+6% +$42.4K 0.01% 1041
2020
Q4 		$605K Sell
3,960
-5,180
-57% -$930K 0.01% 982
2020
Q3 		$1.7M Buy
9,140
+5,550
+155% +$909K 0.03% 554
2020
Q2 		$435K Buy
+3,590
New +$365K 0.01% 860

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Schonfeld Strategic Advisors's IMUX Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Immunic (IMUX) in Q1 2026: 2,830 shares worth $31.4K. The stake represents ﹤0.01% of the portfolio and ranks #2019 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in IMUX as recently as Q1 2025.

Schonfeld Strategic Advisors first reported a position in IMUX in Q2 2020 and has held it in 19 quarters since. The position peaked at $1.7M in Q3 2020. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Schonfeld Strategic Advisors held 2,830 shares of Immunic worth $31.4K as of Q1 2026.
  • Immunic was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Immunic made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #2019 holding.
  • Schonfeld Strategic Advisors first reported a position in Immunic in Q2 2020 and has held it in 19 quarters since.
  • Schonfeld Strategic Advisors's Immunic position peaked at $1.7M in Q3 2020.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.